Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine with fospropofol disodium for anesthetic induction in thoracic surgery
ChiCTR2600116058Phase 4Not yet recruiting
- Sponsor
- Tai'an City Central Hospital
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in postoperative pain (2 arms), sponsored by Tai'an City Central Hospital. Primary endpoint: Incidence of adverse body movement reactions during the induction period. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2600116058.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600116058.